Impact of clinical pharmacist medication review on appropriate prescribing in elderly patients: A randomized, controlled trial
Not Applicable
Completed
- Conditions
- inappropriate prescribing
- Registration Number
- ACTRN12617000665336
- Lead Sponsor
- Pamela Youde Nethersole Eastern Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie inappropriate prescribing in elderly patients as assessed by the Medication Appropriateness Index?
How does clinical pharmacist medication review compare to standard-of-care prescribing practices in reducing inappropriate medication use in geriatric populations?
Are there specific biomarkers or patient characteristics that predict improved outcomes from pharmacist-led medication reviews in elderly patients?
What are the potential adverse events associated with pharmacist interventions in optimizing drug therapy for elderly patients with inappropriate prescribing?
What drug classes or combination approaches are most commonly recommended by clinical pharmacists to address inappropriate prescribing in geriatric care?